How Often Should You Take Peptides?

Introduction

Peptide dosing frequency is dictated by the molecule’s half-life and what tissue you’re trying to reach. BPC-157 is typically dosed once or twice daily. Ipamorelin and CJC-1295 without DAC pulse two to three times daily for shorter peptides, while CJC-1295 with DAC is dosed weekly. GLP-1 peptides like semaglutide are weekly. Tesamorelin is daily.

There is no universal peptide schedule. Each molecule has its own pharmacokinetics, and copy-pasting a friend’s protocol is the most common reason a peptide cycle fails to do anything.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

How Does Half-life Determine Dosing?

A peptide’s half-life is the time for its plasma concentration to drop by half. Short half-life peptides need frequent dosing to maintain effective levels. Long half-life peptides can be dosed less often.

Quick Answer: BPC-157: typically 1 to 2 daily doses, oral or subcutaneous

BPC-157 has a measured half-life of roughly 4 hours in rodent plasma. To maintain anything close to steady exposure you’d need 6 daily doses, which isn’t practical. Most users compromise with once or twice daily and accept the trough periods.

Semaglutide has a half-life of about 168 hours in humans, which is why once-weekly dosing produces stable plasma levels. Tirzepatide is similar at around 120 hours. Both reach steady state after about 4 to 5 weeks of weekly injections.

How Often Should BPC-157 Be Taken?

Most protocols use once-daily oral dosing of 250 to 750 mcg, or twice-daily subcutaneous dosing of 200 to 300 mcg per injection. Cycles run 4 to 12 weeks depending on the indication.

For acute musculoskeletal injuries, twice-daily subcutaneous injection near the injury site is the common approach in informal practice. There’s no controlled human data showing local injection outperforms systemic, but the pharmacology argues for it.

For gut indications, once-daily oral is the standard. The Sikiric group rodent work used oral dosing extensively and reported strong gastric effects, so the oral route appears bioactive for gut tissue.

How Often Should Ipamorelin and CJC-1295 Be Dosed?

The classic ipamorelin and CJC-1295 (no DAC) stack is 2 to 3 subcutaneous injections per day, typically morning, post-workout, and pre-bed. Each peptide is 100 to 300 mcg per dose. Pre-bed dosing matches the natural nocturnal GH pulse.

The reason for multiple daily doses is the short half-life of both peptides (under 30 minutes for CJC-1295 without DAC). Pulsatile dosing approximates the physiological pattern of GH release.

CJC-1295 with DAC is a different molecule because the drug affinity complex binds albumin and extends half-life to about 8 days. It’s dosed once weekly at 1 to 2 mg. The trade-off is that you lose the pulsatile pattern and get sustained GH elevation, which carries higher theoretical IGF-1 risk.

How Often Is Semaglutide Injected?

Compounded semaglutide and brand semaglutide (Ozempic®, Wegovy®) are dosed once weekly. The drug’s long half-life makes more frequent dosing unnecessary and would only raise side effect risk.

Standard titration is 0.25 mg weekly for 4 weeks, then 0.5 mg for 4 weeks, then escalating as tolerated up to a maintenance dose of 1.7 to 2.4 mg weekly. The slow ramp is what makes nausea and GI side effects manageable.

The SURMOUNT trials for tirzepatide and the STEP trials for semaglutide both used the weekly schedule. The full 14.9 percent weight loss in STEP 1 was at 68 weeks; the 20.9 percent in SURMOUNT-1 was at 72 weeks. These outcomes assume consistent weekly dosing for over a year.

What’s the Dosing for Tirzepatide?

Tirzepatide is once weekly, titrated from 2.5 mg over several months to a maintenance of 5, 7.5, 10, 12.5, or 15 mg depending on tolerance and response. The titration timeline matches what was used in SURPASS for diabetes and SURMOUNT for obesity.

The SURMOUNT-OSA trial (FDA-approved December 2024 for obstructive sleep apnea) also used the weekly schedule. There’s no published data on different dosing intervals.

Key Takeaway: CJC-1295 with DAC: once weekly, due to albumin binding

When Is Dosing “as Needed” Appropriate?

PT-141 (bremelanotide) is the main as-needed peptide. The FDA-approved version (Vyleesi) is dosed 45 minutes before anticipated sexual activity, not on a daily schedule. Effects last 8 to 16 hours.

There’s no value in daily PT-141 dosing. The drug works by activating melanocortin receptors in the central nervous system, and repeated dosing without time between exposures may cause receptor desensitization or sustained flushing and nausea.

How Long Should a Peptide Cycle Run?

Most protocols are 4 to 12 weeks. Cycles longer than 12 weeks risk receptor desensitization for the GH secretagogues and have insufficient long-term safety data for most peptides.

For GLP-1 medications, the model is different. Semaglutide and tirzepatide are intended as long-term maintenance therapy. The STEP 4 trial showed that stopping semaglutide led to weight regain, supporting indefinite dosing for those who tolerate it.

Should Peptides Be Timed to Meals or Sleep?

For BPC-157 oral, fasting is the conventional recommendation to maximize gut tissue exposure. Empty stomach for 30 minutes before and after.

For GH secretagogues like ipamorelin and CJC-1295, fasted state matters because food, especially carbohydrate, blunts GH release. Pre-bed dosing is on an empty stomach naturally and stacks with the physiological nocturnal GH pulse.

For semaglutide and tirzepatide, dosing timing doesn’t matter for the drug’s effect because steady state is maintained across the week. Most patients pick a consistent weekly day for adherence.

Bottom line: PT-141: as needed before activity, not on a daily schedule

FAQ

Can I Take Multiple Peptides on the Same Day?

Yes, this is the basis of stacks like ipamorelin and CJC-1295. Some stacks are well-established (BPC-157 plus TB-500 for injury). Others, like BPC-157 plus GLP-1, are common in practice but lack interaction studies.

What Happens If I Miss a Dose of Weekly Semaglutide?

If the missed dose is within 5 days, take it as soon as you remember. If more than 5 days have passed, skip it and resume the next scheduled dose. Don’t double up.

How Do I Know If I’m Taking Peptides Too Often?

Side effects that grow with each dose, loss of effect (tachyphylaxis), and laboratory abnormalities (elevated IGF-1, blood sugar shifts) are the warning signs. Working with a clinician who can run baseline and follow-up labs is the standard of care.

Should I Cycle Off Ipamorelin and CJC-1295?

Most protocols include 4-week breaks every 8 to 12 weeks to limit receptor desensitization. There’s no controlled trial proving this is necessary, but the biology of pituitary GH release supports it.

How Often Should I Inject TrimRx Compounded Semaglutide?

Once weekly, on the same day each week, subcutaneously into abdomen, thigh, or upper arm. TrimRx ships pre-filled doses and a clinician sets the titration schedule through the free assessment quiz.

Is Daily Semaglutide Injection a Thing?

No. The pharmacokinetics don’t support daily dosing. The oral form (Rybelsus®) is daily because oral absorption is much lower than subcutaneous and requires daily intake to maintain plasma levels.

Can Peptide Frequency Be Reduced Once Results Appear?

For GH secretagogues, dropping from twice daily to once daily is sometimes done in maintenance phases. For GLP-1 medications, the weekly schedule should not be stretched because plasma levels would fluctuate and side effects could increase on each new dose. Working with the prescribing clinician is essential.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.